Literature DB >> 11282228

Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles.

A Lippacher1, R H Müller, K Mäder.   

Abstract

Aqueous dispersions of solid lipid nanoparticles (SLN) show some interesting features in topical drug delivery. However, to get a semisolid carrier having the appropriate consistency for topical application, the liquid SLN dispersions have to be incorporated in convenient topical dosage forms like hydrogels or creams. This is a time-consuming production process with several disadvantages. A new one-step production process delivering a semisolid topical formulation including SLN is presented avoiding these disadvantages. The semisolid SLN dispersions were produced by high-pressure homogenization using an APV Lab 40 homogenizer. The resulting dispersions were characterized concerning their particle size and rheological properties. Despite the high lipid content of the SLN dispersions, they retained their colloidal particle size. Viscoelastic measurements proved the existence of a gel-like structure with a prevailing elastic component.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282228     DOI: 10.1016/s0378-5173(00)00623-2

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  16 in total

1.  Hollow-layered nanoparticles for therapeutic delivery of peptide prepared using electrospraying.

Authors:  Manoochehr Rasekh; Christopher Young; Marta Roldo; Frédéric Lancien; Jean-Claude Le Mével; Sassan Hafizi; Zeeshan Ahmad; Eugen Barbu; Darek Gorecki
Journal:  J Mater Sci Mater Med       Date:  2015-10-08       Impact factor: 3.896

2.  Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration.

Authors:  Vanna Sanna; Nathalie Kirschvink; Pascal Gustin; Elisabetta Gavini; Isabelle Roland; Luc Delattre; Brigitte Evrard
Journal:  AAPS PharmSciTech       Date:  2004-03-10       Impact factor: 3.246

3.  Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation.

Authors:  Maha Nasr; Samar Mansour; Nahed D Mortada; A A El Shamy
Journal:  AAPS PharmSciTech       Date:  2008-01-25       Impact factor: 3.246

4.  Multiple Lipid Nanoparticles (MLN), a New Generation of Lipid Nanoparticles for Drug Delivery Systems: Lamivudine-MLN Experimental Design.

Authors:  Suellen M T Cavalcanti; Cláudia Nunes; Sofia A C Lima; José L Soares-Sobrinho; Salette Reis
Journal:  Pharm Res       Date:  2017-03-17       Impact factor: 4.200

5.  Engineering solid lipid nanoparticles for improved drug delivery: promises and challenges of translational research.

Authors:  Dinesh Kumar Mishra; Vinod Dhote; Punit Bhatnagar; Pradyumna Kumar Mishra
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

Review 6.  The Impact of Variables on Particle Size of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers; A Comparative Literature Review.

Authors:  Leila Azhar Shekoufeh Bahari; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2016-06-30

7.  In situ nanostructured hydrogel of resveratrol for brain targeting: in vitro-in vivo characterization.

Authors:  Amarjitsing Rajput; Aditi Bariya; Ahmed Allam; Sarah Othman; Shital B Butani
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

8.  Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery.

Authors:  Mangesh R Bhalekar; Varsha Pokharkar; Ashwini Madgulkar; Nilam Patil; Nilkanth Patil
Journal:  AAPS PharmSciTech       Date:  2009-03-18       Impact factor: 3.246

9.  Solid lipid nanoparticles as delivery systems for bromocriptine.

Authors:  Elisabetta Esposito; Martina Fantin; Matteo Marti; Markus Drechsler; Lydia Paccamiccio; Paolo Mariani; Elisa Sivieri; Francesco Lain; Enea Menegatti; Michele Morari; Rita Cortesi
Journal:  Pharm Res       Date:  2008-01-03       Impact factor: 4.200

10.  Nanolipidgel for enhanced skin deposition and improved antifungal activity.

Authors:  Preeti Wavikar; Pradeep Vavia
Journal:  AAPS PharmSciTech       Date:  2012-12-21       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.